A detailed history of Farther Finance Advisors, LLC transactions in Nevro Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 60 shares of NVRO stock, worth $271. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 65 7.69%
Holding current value
$271
Previous $560,000 40.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$4.71 - $10.1 $23 - $50
-5 Reduced 7.69%
60 $335,000
Q2 2024

Jul 31, 2024

SELL
$7.96 - $13.59 $159 - $271
-20 Reduced 23.53%
65 $560,000
Q1 2024

May 13, 2024

SELL
$13.56 - $20.78 $2,291 - $3,511
-169 Reduced 66.54%
85 $1.13 Million
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $3,601 - $5,666
254 New
254 $5.47 Million
Q4 2022

Sep 11, 2023

BUY
$36.43 - $49.4 $218 - $296
6 New
6 $238,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.